Designed to make market research more actionable and strategically valuable, The Business Research Company’s 2026 market reports feature market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights.
What Is The Projected CAGR Of The Imaging Chemicals Market Through 2030?
The imaging chemicals market has experienced substantial growth in recent years. This market is projected to expand from $27.93 billion in 2025 to $29.93 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.2%. Historically, this expansion has been driven by factors such as the growth of packaging and label printing, the expansion of medical imaging diagnostics, the increasing application of chemical developers, consistent demand in textile printing, and the readily available conventional imaging chemicals.
The imaging chemicals market is projected to experience robust expansion over the coming years. This market is set to reach $38.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.7%. The projected growth during this period stems from factors such as the greater embrace of digital printing technologies, an escalating need for sustainable inks and toners, the broadening scope of healthcare imaging applications, increased funding for specialty chemical innovation, and heightened regulatory attention on low-VOC formulations. Key trends anticipated for the forecast period encompass a noticeable shift towards digital imaging chemicals, growing requirements for high-resolution printing inks, wider application in medical diagnostic imaging, the development of more eco-friendly imaging formulations, and improved capabilities of specialty toners.
Claim Your Free Imaging Chemicals Market Sample Report With Key Data And Trends:
Imaging Chemicals Market Demand Analysis: The Driving Force Behind Expansion
The rising occurrence of chronic illnesses is anticipated to fuel expansion within the imaging chemicals market in the upcoming period. These long-term medical conditions, also referred to as non-communicable diseases (NCDs), are defined by their enduring and extended duration. Essential for the diagnosis, monitoring, and treatment of chronic ailments, imaging chemicals function as contrast agents or tracers in diverse imaging techniques, allowing medical experts to observe internal anatomy, pinpoint irregularities, and evaluate the advancement of chronic conditions. As an illustration, data from July 2024 by the Australian Institute of Health and Welfare (AIHW), an Australia-based governmental health statistics body, indicated that chronic conditions were responsible for 78% of the fatal burden, an increase from prior years. Consequently, the growing incidence of chronic diseases is stimulating the imaging chemicals market.
Breaking Down The Imaging Chemicals Market By Segment
The imaging chemicals market covered in this report is segmented –
1) By Product Type: Imaging Agents And Toners, Printing Inks, Image Developers
2) By Application: Medical Diagnostics, Packaging And Printing, Textile Processing, Mining, Other Applications
3) By Form: Liquid, Powder
Subsegments:
1) By Imaging Agents And Toners: Liquid Toners, Powder Toners, Imaging Agents For Medical Imaging
2) By Printing Inks: Solvent-Based Inks, Water-Based Inks, UV-Curable Inks, Eco-Friendly Inks
3) By Image Developers: Photographic Developers, Digital Imaging Developers, Chemical Developers For X-Ray Imaging
Top Trend Influencing The Imaging Chemicals Market Outlook
Leading companies within the imaging chemicals market are concentrating on creating novel solutions, such as advanced gadolinium-based contrast agents (GBCAs), to satisfy the increasing need for diagnostic imaging that is safer, more efficient, and provides higher resolution. These cutting-edge contrast agents provide enhanced relaxivity and necessitate smaller doses compared to conventional formulations, thereby mitigating safety issues related to gadolinium exposure and enabling sharper, more accurate MRI visualization. As an example, in February 2023, the Guerbet Group, a pharmaceutical and medical imaging company based in France, introduced its Elucirem (gadopiclenol) injection. This newest generation GBCA from Guerbet delivers the highest relaxivity in the magnetic resonance imaging (MRI) category and is approved for use in adults and children aged 2 years and older. Elucirem needs only half the gadolinium dosage compared to conventional non-specific GBCAs, which eases practitioners’ concerns regarding gadolinium exposure. The Elucirem (gadopiclenol) injection facilitates the detection and visualization of lesions exhibiting abnormal vascularity within the central nervous system (comprising the brain, spine, and associated tissues) as well as across the body (including the head and neck, chest, stomach, pelvis, and musculoskeletal system).
Imaging Chemicals Market Competitive Landscape And Major Players
Major companies operating in the imaging chemicals market are Eastman Kodak Company, Agfa-Gevaert NV, Altana AG, BASF SE, Clariant Chemical Company, DIC Corporation, Dow Chemical Company, Flint Group S.A., FUJIFILM Holdings Corporation, Hubergroup Deutschland GmbH, Kao Corporation, Kodak Alaris Inc., Qingdao Scienoc Chemical Co., Sakata Inx Corp., Siegwerk Druckfarben AG & Co. KGaA, T&K TOKA Corporation, Toyo Ink SC Holdings Co. Ltd., Wikoff Color Corporation, Evonik Industries AG, Merck Co. & KGaA
Read The Full Imaging Chemicals Market Report By The Business Research Company:
Where Is The Imaging Chemicals Market Largest? Key Regional Insights
Asia-Pacific was the largest region in the imaging chemicals market in 2025. The regions covered in the imaging chemicals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
